Tumor Mutational Burden Arises as an Actionable Biomarker in NSCLC

Press/Media: Press / Media

PeriodOct 16 2018

Media coverage

1

Media coverage

  • TitleTumor Mutational Burden Arises as an Actionable Biomarker in NSCLC
    Media name/outletTargeted Oncology
    CountryUnited States
    Date10/16/18
    PersonsDennis Lowenthal